InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+30.8%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Kirsch Arthur S, Director. Officer active across 6 companies, notably Kadmon Holdings, Inc.. Aggregated, 9 filings have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €226k. Activity tracked since 13 May 2021. The latest transaction was filed on 7 July 2026 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Kirsch Arthur S
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
10,000 shares@ US$13.300.030% mcap100.0% of flowCommon StockSEC:0001290976-26-000004:0
Canonical exit: 5 Oct 2026 (T+90)
18,396 shares0Common StockSEC:0001104659-25-061190:0
20,359 shares0Common StockSEC:0001104659-24-074472:0
30,000 shares@ US$4.24100.0% of flowCommon StockSEC:0001104659-21-138087:0
Canonical exit: 8 Feb 2022 (T+90)
30,000 shares@ US$9.5080.6% of flowCommon StockSEC:0001104659-21-136408:0
20,000 shares@ US$3.5819.4% of flowCommon stockSEC:0001593968-21-001331:0
64,719 sharesCommon SharesSEC:0001104659-16-095173:0
6,107 sharesCommon StockSEC:0001104659-16-094738:0
6,107 sharesCommon StockSEC:0001104659-16-091019:0
9 of 9 declarations
About Kirsch Arthur S
Arthur S. Kirsch serves as a Board Member at Kadmon Holdings, Inc. and Liquidia Corp. In this role, he oversees the operations of these companies and participates in strategic decision-making. His expertise in the biopharmaceutical sector allows him to provide significant contributions to the board.
